Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications
Antioxidants & Redox Signaling · 2024-12 · 41 (16-18) · 1073-1099
DOI: 10.1089/ars.2024.0676 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 10.12.2024. Verfasst von Ziying Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sam and Ann Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Myelin Sheath, Lipid Metabolism. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 301 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Significance: Lipids, which constitute the highest portion (over 50%) of brain dry mass, are crucial for brain integrity, energy homeostasis, and signaling regulation. Emerging evidence revealed that lipid profile alterations and abnormal lipid metabolism occur during normal aging and in different forms of neurodegenerative diseases. Moreover, increasing genome-wide association studies have validated new targets on lipid-associated pathways involved in disease development. Myelin, the protective sheath surrounding axons, is crucial for efficient neural signaling transduction. As the primary site enriched with lipids, impairments of myelin are increasingly recognized as playing significant and complex roles in various neurodegenerative diseases, beyond simply being secondary effects of neuronal loss. Recent Advances: With advances in the lipidomics field, myelin lipid alterations and their roles in contributing to or reflecting the progression of diseases, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, multiple sclerosis, and others, have recently caught great attention. Critical Issues: This review summarizes recent findings of myelin lipid alterations in the five most common neurodegenerative diseases and discusses their implications in disease pathogenesis. Future Directions: By highlighting myelin lipid abnormalities in neurodegenerative diseases, this review aims to encourage further research focused on lipids and the development of new lipid-oriented therapeutic approaches in this area. Antioxid. Redox Signal. 00, 000–000.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sam and Ann Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, Texas, USA.
- Department of Medicine, UT Health San Antonio, San Antonio, Texas, USA.
ORCID-Profile: Ziying Xu
Förderung
- NIA NIH HHS
Zitieren
APA
Xu, Z., He, S., Begum, M. M., & Han, X. (2024). Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications. Antioxidants & Redox Signaling, 41(16-18), 1073-1099. https://doi.org/10.1089/ars.2024.0676
Vancouver
Xu Z, He S, Begum MM, Han X. Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications. Antioxidants & Redox Signaling. 2024;41(16-18):1073-1099. doi:10.1089/ars.2024.0676
BibTeX
@article{Xu2024,
author = {Xu, Ziying and He, Sijia and Begum, Mst Marium and Han, Xianlin},
title = {Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications},
journal = {Antioxidants & Redox Signaling},
year = {2024},
volume = {41},
number = {16-18},
pages = {1073--1099},
doi = {10.1089/ars.2024.0676}
}
EUVIMED